Abstract
Purpose
Extracorporeal shock wave lithotripsy (ESWL) requires sedation in pediatric patients. Dexmedetomidine is a relatively new agent used for sedation. The aim of this randomized prospective study was to compare the effects of dexmedetomidine–ketamine and midazolam–ketamine combinations on the recovery time, hemodynamic and respiratory variables, and side effects in pediatric patients undergoing ESWL.
Methods
Fifty pediatric patients aged between 2 and 15 years who were scheduled for elective ESWL were randomized into two groups. In Group D we applied dexmedetomidine at1 μg/kg, given over 10 min, and a bolus of 1 mg/kg ketamine for sedation. In Group M we applied midazolam at a 0.05 mg/kg bolus dose 10 min before the procedure and a 1 mg/kg bolus of ketamine. We measured and monitored the hemodynamic variables, oxygen saturation, and recovery time, and we also monitored the side effects.
Results
Four patients in group D refused to complete the study; 21 patients in group D and 25 patients in group M completed the study. We found the recovery time [eye-opening time (9.3 ± 4.5 vs. 16.2 ± 6.5 min; p < 0.001), verbal response time (12.8 ± 4.9 vs. 19.2 ± 7.2 min; p < 0.001), and the cooperation time (17.1 ± 5.0 vs. 23.3 ± 7.7 min; p < 0.001)] to be shorter in the dexmedetomidine group. Also, the heart rate values were lower in the dexmedetomidine group at the 20th minute of the procedure (99.1 ± 19.0 vs. 118.7 ± 7.3 beats/min; p = 0.016).
Conclusion
In this study we found the recovery time to be shorter, with hemodynamic stability, in the dexmedetomidine group, compared with the midazolam group. So we can conclude that dexmedetomidine may be a good and safe alternative agent for sedation, with a shorter recovery period than midazolam, in the pediatric population.
Similar content being viewed by others
References
Graff J, Diederichs W, Shulze H. Long-term follow up in 1003 extracorporeal shock wave lithotripsy patients. J Urol. 1988;140:479–83.
Brinkmann OA, Griehl A, Kuwertz-Bröking E, Bulla M, Hertle L. Extracorporeal shock wave lithotripsy in children. Efficacy, complications and long-term follow-up. Eur Urol. 2001;39:591–7.
Muslumanoglu AY, Tefekli AH, Altunrende F, Karadag MA, Baykal M, Akcay M. Efficacy of extracorporeal shock wave lithotripsy for ureteric stones in children. Int Urol Nephrol. 2006;38:225–9.
Erden IA, Artukoglu F, Gozacan A, Ozgen S. Comparison of propofol/fentanyl and ketamine anesthesia in children during extracorporeal shockwave lithotripsy. Saudi Med J. 2007;28(3):364–8.
Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimaroglu C, Gultekin Y. A comparison of sedation with dexmedetomidine or propofol during shock wave lithotripsy: a randomized controlled trial. Anesth Analg. 2008;106:114–9.
Slavik VC, Zed PJ. Combination ketamine and propofol for procedural sedation and analgesia. Pharmacotherapy. 2007;27:1588–98.
Cox RG, Nemish U, Ewen A, Crowe M-J. Evidence-based clinical update: does premedication with oral midazolam lead to improved behavioural outcomes in children? Can J Anaesth. 2006;53:1213–9.
Jobeir A, Galal MO, Bulbul ZR, Solymar L, Darwish A, Schmaltz AA. Use of low-dose ketamine and/or midazolam for pediatric cardiac catheterization: ıs an anesthesiologist needed? Pediatr Cardiol. 2003;24:236–43.
Kauppila T, Kemppainen P, Tanila H, Pertovaara A. Effect of systemic medetomidine, an alpha 2 adrenoreceptor agonist, on experimental pain in humans. Anesthesiology. 1991;74:3–8.
Venn R, Bradshaw C, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM. Preliminary experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136–42.
Mukhtar AM, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg. 2006;103:52–6.
Mason KP, Zgleszewski SE, Dearden JL, Dumont RS, Pirich MA, Stark CD, D’Angelo P, Macpherson S, Fontaine PJ, Connor L, Zurakowski D. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg. 2006;103:57–62.
Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth. 2005;94:821–4.
Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alphaxalone–alphadolone. Br Med J. 1974;2:656–9.
Aldrete JA, Kronlik D. A postanesthetic recovery score. Anesth Analg. 1970;49:924.
White PF, Way WL, Trevor AJ. Ketamine: pharmacology and therapeutic uses. Anesthesiology. 1982;56:119–36.
Monk TG, Rater JM, White PF. Comparison of alfentanil and ketamine infusions in combination with midazolam for outpatient lithotripsy. Anesthesiology. 1991;74:1023–8.
Tosun Z, Akin A, Guler G, Esmaoglu A, Boyaci A. Dexmedetomidine–ketamine and propofol–ketamine combinations for anesthesia in spontaneously breathing pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth. 2006;20:515–9.
Berman WJ, Fripp RR, Rubler M. Hemodynamic effects of ketamine in children undergoing cardiac catheterization. Pediatr Cardiol. 1990;11:72–6.
Oklu E, Bulutcu FS, Yalcin Y, Ozbek U, Cakali E, Bayindir O. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol versus ketamine. J Cardiothorac Vasc Anesth. 2003;17:686–90.
Rutman MS. Sedation for emergent diagnostic imaging studies in pediatric patients. Curr Opin Pediatr. 2009;21:306–12.
Jaakola ML, Salonen M, Lehtinen R, Scheinin H. The analgesic action of dexmedetomidine––a novel alpha 2-adrenoceptor agonist–in healthy volunteers. Pain. 1991;46:281–5.
Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–94.
Alhashemi JA, Kaki AM. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy. Can J Anaesth. 2004;51:342–7.
Talke P, Lobo E, Brown R. Systemically administered alpha2agonist-induced peripheral vasoconstriction in humans. Anesthesiology. 2003;99:65–70.
Talke P, Richardson CA, Scheinin M, Fischer DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg. 1997;85:1136–42.
Mason KP, Zgleszewski SE, Prescilla R, Fontaine PS, Zurakowski D. Hemodynamic effects of dexmedetomidine sedation for CT imaging studies. Paediatr Anaesth. 2008;18:393–402.
Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134–42.
Koroglu A, Teksan H, Sagir O, Yucel A, Toprak HI, Ersoy OM. A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg. 2006;103:63–7.
Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993;78:813–20.
Koruk S, Mizrak A, Kaya Ugur B, Ilhan O, Baspinar O, Oner U. Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: a prospective randomized study. Clin Ther. 2010;32:701–9.
Ohtani N, Kida K, Shoji K, Yasui Y, Masaki E. Recovery profiles from dexmedetomidine as a general anesthetic adjuvant in patients undergoing lower abdominal surgery. Anesth Analg. 2008;107:1871–4.
Erdil F, Demirbilek S, Begec Z, Ozturk E, Ulger MH, Ersoy MO. The effects of dexmedetomidine and fentanyl on emergence characteristics after adenoidectomy in children. Anaesth Intensive Care. 2009;37:571–6.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Koruk, S., Mizrak, A., Gul, R. et al. Dexmedetomidine–ketamine and midazolam–ketamine combinations for sedation in pediatric patients undergoing extracorporeal shock wave lithotripsy: a randomized prospective study. J Anesth 24, 858–863 (2010). https://doi.org/10.1007/s00540-010-1023-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-010-1023-1